Skip to main content
. 2017 Dec 14;103(3):456–465. doi: 10.3324/haematol.2017.178442

Figure 4.

Figure 4.

Refinement of the European LeukemiaNet (ELN) 2017 genetic risk classification (ELN2017) by predictive score PS29MRC. (A) Pie charts showing the distribution of patients according to ELN2017 and refined risk criteria. (B) Kaplan-Meier estimates of acute myeloid leukemia (AML) patients in the validation set according to ELN2017 and the refined ELN2017 classification. (C) Scheme of reclassification of the three ELN2017 risk groups into four groups by integrating PS29MRC as a dichotomous variable (PS29MRCdic) (high risk) with the ELN2017 risk classification.